Immunopharmacology and Immunotoxicology · 2000 · 16 citations · 19 references
Life SciencesCell BiologyPharmacologyApoptosisCell SignalingSignal TransductionApoptosis In CancerApoptosis RegulationApoptosis ResistanceApoptotic Signal TransductionApoptotic SignalingCancer Cell SignalingAnti-apoptotic AgentsApoptosis Regulation By KinasesApoptosis Signaling In CancerApoptosis Signaling PathwaysApoptosis-related Kinase CascadesApoptotic Signaling In CancerProtein Kinase InhibitorsSignal Transduction Pathway Activation
The purpose of this study was to evaluate whether the mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK) signaling pathway contributes to 12-O-tertadecanoyl phorbol 13-acetate (TPA)-mediated protection from taxol-induced apoptosis of human leukemia HL-60 cells. Treatment of cells with taxol for 12 h resulted in apoptosis of HL-60 cells. TPA was protective against taxol-induced apoptosis and this anti-apoptotic effect was reversible when TPA was used in conjunction with staurosporine and H-7, PKC inhibitors, suggesting that TPA may protect HL-60 cells against taxol-induced apoptosis via the PKC-dependent pathway. Since TPA stimulates MEK signal transduction pathway in HL-60 cells, we postulated that MEK pathway may be playing a role in the ability of TPA to inhibit taxol-induced apoptosis. PD098059, a specific MEK kinase inhibitor, abolished the ability of TPA to inhibit taxol-induced apoptosis. These results suggest that activation of PKC in HL-60 cells confers protection against taxol-induced apoptosis and that MEK mediates anti-apoptotic signaling of PKC.
19
Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
Olivier Cuvillier, Grisha Pirianov, Burkhard Kleuser et al. · Nature · 1996 · 1.5K citations
Joseph T. Neary, Yuan Kang, Yurong Bu et al. · Journal of Neuroscience · 1999 · 203 citations · Full text